0.00
price down icon100.00%   -4.84
after-market Handel nachbörslich: 4.85 4.85 +
loading
Schlusskurs vom Vortag:
$4.84
Offen:
$0
24-Stunden-Volumen:
0
Relative Volume:
0.00
Marktkapitalisierung:
$633.18M
Einnahmen:
$25.81M
Nettoeinkommen (Verlust:
$-188.12M
KGV:
0.00
EPS:
-1.4503
Netto-Cashflow:
$-183.77M
1W Leistung:
-100.00%
1M Leistung:
-100.00%
6M Leistung:
-100.00%
1J Leistung:
-100.00%
1-Tages-Spanne:
Value
$0.00
$0.00
1-Wochen-Bereich:
Value
$0.00
$0.00
52-Wochen-Spanne:
Value
$0.00
$7.91

Exscientia Plc Adr Stock (EXAI) Company Profile

Name
Firmenname
Exscientia Plc Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
483
Name
Twitter
Name
Nächster Verdiensttermin
2024-11-07
Name
Neueste SEC-Einreichungen
Name
EXAI's Discussions on Twitter

Vergleichen Sie EXAI mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
EXAI
Exscientia Plc Adr
0.00 633.18M 25.81M -188.12M -183.77M -1.4747
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
397.27 102.31B 10.63B -479.80M -1.35B -1.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
701.85 77.13B 13.85B 4.65B 3.32B 40.41
Biotechnology icon
ARGX
Argen X Se Adr
623.82 37.30B 1.86B -40.29M -1.28B -0.85
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
245.44 31.66B 2.09B -332.26M 16.06M -2.62
Biotechnology icon
BNTX
Biontech Se Adr
113.08 27.11B 3.30B -501.07M 1.03B -2.1146

Exscientia Plc Adr Stock (EXAI) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-07-09 Eingeleitet TD Cowen Buy
2024-01-05 Herabstufung BofA Securities Buy → Neutral

Exscientia Plc Adr Aktie (EXAI) Neueste Nachrichten

pulisher
Dec 15, 2024

Exscientia's SWOT analysis: ai biotech stock faces merger challenges - Investing.com India

Dec 15, 2024
pulisher
Dec 15, 2024

Exscientia's SWOT analysis: ai biotech stock faces merger challenges By Investing.com - Investing.com South Africa

Dec 15, 2024
pulisher
Nov 21, 2024

Exscientia's SWOT analysis: ai-driven biotech stock faces merger challenges - Investing.com

Nov 21, 2024
pulisher
Nov 20, 2024

Exscientia and Recursion Merge to Revolutionize Drug Discovery - TipRanks

Nov 20, 2024
pulisher
Nov 13, 2024

Recursion Pharmaceuticals secures stockholder nod for Exscientia acquisition - Investing.com

Nov 13, 2024
pulisher
Nov 13, 2024

Recursion Pharmaceuticals secures stockholder nod for Exscientia acquisition By Investing.com - Investing.com UK

Nov 13, 2024
pulisher
Nov 13, 2024

Recursion, Exscientia shareholders back merger - Investing.com

Nov 13, 2024
pulisher
Nov 12, 2024

Such Is The Power Of Verizon Communications Inc (NYSE: VZ) - Stocks Register

Nov 12, 2024
pulisher
Oct 16, 2024

Quarterly Metrics: Quick and Current Ratios for Exscientia Plc ADR (EXAI) - The Dwinnex

Oct 16, 2024
pulisher
Oct 16, 2024

Exscientia advances two drug programs with Sanofi By Investing.com - Investing.com South Africa

Oct 16, 2024
pulisher
Oct 16, 2024

Exscientia advances two drug programs with Sanofi - Investing.com

Oct 16, 2024
pulisher
Oct 15, 2024

How to interpret Exscientia Plc ADR (EXAI)’s stock chart patterns - US Post News

Oct 15, 2024
pulisher
Oct 11, 2024

Recursion’s All-Stock Acquisition of Exscientia plc (EXAI): NVIDIA-Backed Merger to Revolutionize AI-Driven Drug Discovery - Yahoo Finance

Oct 11, 2024
pulisher
Oct 06, 2024

Harrow (HROW) Surges 8.4%: Is This an Indication of Further Gains? - MSN

Oct 06, 2024
pulisher
Oct 02, 2024

Investing in Exscientia Plc ADR (EXAI) might be a great opportunity, but the stock is a bit undervalued - US Post News

Oct 02, 2024
pulisher
Sep 30, 2024

Exscientia Plc ADR (EXAI)’s Market Momentum: Closing Strong at 5.06, Down -4.53 - The Dwinnex

Sep 30, 2024
pulisher
Sep 30, 2024

Taking on analysts’ expectations and winning: Exscientia Plc ADR (EXAI) - SETE News

Sep 30, 2024
pulisher
Sep 30, 2024

Exscientia's SWOT analysis: AI biotech stock faces merger, pipeline milestones - Investing.com

Sep 30, 2024
pulisher
Sep 25, 2024

Exscientia Plc ADR (EXAI) expanding its growth trajectory ahead - SETE News

Sep 25, 2024
pulisher
Sep 24, 2024

A stock that deserves closer examination: Exscientia Plc ADR (EXAI) - US Post News

Sep 24, 2024
pulisher
Sep 20, 2024

Take off with Exscientia Plc ADR (EXAI): Get ready for trading - SETE News

Sep 20, 2024
pulisher
Sep 19, 2024

Exscientia Plc ADR (EXAI)’s stock chart: A technical perspective - US Post News

Sep 19, 2024
pulisher
Sep 19, 2024

Market Insights: Exscientia Plc ADR (EXAI)’s Notable Gain of 3.78, Closing at 5.22 - The Dwinnex

Sep 19, 2024
pulisher
Sep 19, 2024

EXAI’s 52-Week Rollercoaster: From $3.80 to $7.91 – What’s Next for Investors? - The InvestChronicle

Sep 19, 2024
pulisher
Sep 10, 2024

Closing Figures Unveiled: Exscientia Plc ADR (EXAI) Drop -1.02, Closes at 4.85 - The Dwinnex

Sep 10, 2024
pulisher
Sep 10, 2024

EXAI (Exscientia Plc ADR) has impressive results - US Post News

Sep 10, 2024
pulisher
Sep 05, 2024

Check out these key findings about Exscientia Plc ADR (EXAI) - SETE News

Sep 05, 2024
pulisher
Sep 04, 2024

Exscientia Plc ADR (EXAI) Stock: A Year of Market Fluctuations - The InvestChronicle

Sep 04, 2024
pulisher
Sep 04, 2024

Are Investors Keen On Selling Holdings In N2OFF Inc. (NASDAQ: NITO)? - Stocks Register

Sep 04, 2024
pulisher
Sep 03, 2024

Daily Market Movement: Exscientia Plc ADR (EXAI) Sees a -1.77 Decrease, Closing at 5.56 - The Dwinnex

Sep 03, 2024
pulisher
Aug 29, 2024

Ratios Reveal: Breaking Down Exscientia Plc ADR (EXAI)’s Financial Health - The Dwinnex

Aug 29, 2024
pulisher
Aug 29, 2024

AI in Pharma and Biotech Market Projected Growth at 18.8% CAGR to Reach USD 13.1 billion by 2034 | Exclusive Research Report by Transparency Market Research Inc. - GlobeNewswire Inc.

Aug 29, 2024
pulisher
Aug 28, 2024

Exscientia to Present at the Morgan Stanley 22 nd Annual Global Healthcare Conference - TT Nyhetsbyrån

Aug 28, 2024
pulisher
Aug 28, 2024

Recursion Pharmaceuticals secures key shareholder support - Investing.com

Aug 28, 2024
pulisher
Aug 26, 2024

What technical indicators reveal about EXAI stock - US Post News

Aug 26, 2024
pulisher
Aug 21, 2024

Deeper Dive: Understanding Exscientia Plc ADR (EXAI) Through its Various Ratios - The Dwinnex

Aug 21, 2024
pulisher
Aug 19, 2024

Have you been able to find a good deal on Exscientia Plc ADR’s shares? - US Post News

Aug 19, 2024
pulisher
Aug 17, 2024

Exscientia Plc ADR (EXAI) Is Worth Accumulating At Current Levels - Stocks Register

Aug 17, 2024
pulisher
Aug 15, 2024

EXAI’s Stock Market Puzzle: Piecing Together 2023’s Performance - The InvestChronicle

Aug 15, 2024
pulisher
Aug 14, 2024

Market Resilience: Exscientia Plc ADR (EXAI) Finishes Strong at 5.00, Up 2.88 - The Dwinnex

Aug 14, 2024
pulisher
Aug 14, 2024

Taking the lead: Exscientia Plc ADR (EXAI) - SETE News

Aug 14, 2024
pulisher
Aug 12, 2024

Examining Exscientia Plc ADR (EXAI) stock is warranted - US Post News

Aug 12, 2024
pulisher
Aug 10, 2024

Before Buying Exscientia Plc ADR (NASDAQ: EXAI) Stock, Read This First - Stocks Register

Aug 10, 2024
pulisher
Aug 08, 2024

Exscientia stock downgraded to Hold amid Recursion merger - Investing.com

Aug 08, 2024
pulisher
Aug 08, 2024

Recursion and Exscientia announce merger to enhance drug discovery - Investing.com

Aug 08, 2024
pulisher
Aug 08, 2024

Recursion's Acquisition Of Exscientia Makes Sense On Some Levels, Not Others (NASDAQ:EXAI) - Seeking Alpha

Aug 08, 2024
pulisher
Aug 07, 2024

Views of Wall Street’s Leading Experts on Exscientia Plc ADR - SETE News

Aug 07, 2024
pulisher
Aug 07, 2024

EXAI’s Debt-to-Equity Ratio at 0.06: What It Means for Exscientia Plc ADR’s Future - The InvestChronicle

Aug 07, 2024
pulisher
Aug 07, 2024

Amazon (AMZN) Plunges 19.1% in a Month: Should You Buy the Dip? - Zacks Investment Research

Aug 07, 2024
pulisher
Aug 06, 2024

Market Momentum: Exscientia Plc ADR (EXAI) Registers a -8.19 Decrease, Closing at 4.26 - The Dwinnex

Aug 06, 2024
pulisher
Aug 02, 2024

Analyzing the Impact of Earnings Reports on Vivid Seats Inc Inc. (SEAT) Price Performance - The InvestChronicle

Aug 02, 2024

Finanzdaten der Exscientia Plc Adr-Aktie (EXAI)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$17.87
price down icon 2.88%
$68.84
price up icon 2.65%
$39.39
price down icon 0.43%
$359.58
price down icon 0.16%
$176.50
price up icon 1.02%
$113.08
price up icon 1.56%
Kapitalisierung:     |  Volumen (24h):